Robin M. Shaw MD PhD
Adult Congenital Heart Disease, Heart Failure & Transplantation
Wasserman Endowed Chair in Cardiology, Cedars-Sinai Medical Center and UCLA
Join to view full profile
8700 Beverly BlvdWest Hollywood, CA 90048
Phone+1 310-423-5000
Fax+1 310-967-1773
Dr. Shaw is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Cardiovascular Disease, 2001 - 2004- University of California (San Francisco)Residency, Internal Medicine, 1999 - 2001
Case Western Reserve University School of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2000 - 2028
UT State Medical License 2020 - 2028
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Publications & Presentations
PubMed
- Excessive EFHD1-dependent ER-mitochondrial contacts drive a maladaptive antiviral response in metabolic liver disease.David R Eberhardt, Emma C Rekate, Yasmin B Masini, Hannah E Duron, David Mollinedo
The Journal of Clinical Investigation. 2026-10-01 - cBIN1 gene therapy restores ventricular synchrony in a preclinical model of ischemic heart failure.Kyoichiro Yazaki, M Sofia Ruiz Castillo, Muhammad S Khan, Emmanuel Offei, Ankur R Shah
Heart Rhythm. 2026-09-16 - Targeting rotors in ventricular fibrillation: Molecular mechanisms and future therapeutic strategies.Vu D Nguyen, Robin M Shaw
Trends in Cardiovascular Medicine. 2026-05-07
Journal Articles
- The Clinical Course of a Genetic Dilated CardiomyopathyRobin Shaw, MD, ScienceDirect
Press Mentions
Heart Failure Is Reversed with New Gene Therapy in Animal Study: ‘Unprecedented Recovery’December 11th, 2024- Gene Therapy Reverses Heart Failure in New TrialsDecember 10th, 2024
- Gene Therapy Reverses Effects of Heart Failure and Restores Heart Function in MinipigsDecember 10th, 2024
Grant Support
- Novel Gene Therapy For Chronic Ischemic Heart FailureUTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH2024–2027
- Novel Gene Therapy For Chronic Ischemic Heart FailureUTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH2024–2027
- Correcting Cardiac Microdomains Reverses Non-Ischemic CardiomyopathyUTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH2023–2027
- Training in Cardiovascular ResearchUNIVERSITY OF UTAH1994–2027
- Regulation of Cav1.2 Trafficking by GJA1-20k and cBIN1UNIVERSITY OF UTAH2021–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
